CVC-26745-25013 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-31
Registered in v-safe
2020-12-31
Dose 1 — Pfizer-BioNTech
2021-01-01
Survey response — days 1–6 daily, dose 1
MedDRA: Postpartum state — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: 6 days postpartum

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-01
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-02
Survey response — days 1–6 daily, dose 1
MedDRA: Postpartum disorder — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: 1 week postpartum

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-02
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fever · None

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-09
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-14
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-20
Dose 2 — Pfizer-BioNTech
2021-02-11
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-17
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-21
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-23
Survey response — 6 months, dose 2
MedDRA: Asthma, Colitis, Pre-existing disease — Feeling: Good · Be unable to work or attend school

Free text: Asthma flair and colitis.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-10-05
Dose 3 — Pfizer-BioNTech
Co-administered: yes
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-11-09
Survey response — day 35, dose 3
MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activities

Free text: Pregnant

MedDRA releases: 2024-11 · check-in free text available
2021-11-18
Survey response — day 42, dose 3
MedDRA: Pyelonephritis acute — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Acute MDRO pyelo

MedDRA releases: 2024-11 · check-in free text available
2021-11-18
Report sent to call center — day 42, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2021-11-19
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-31	Pfizer-BioNTech
2	2021-01-20	Pfizer-BioNTech
3	2021-10-05	Pfizer-BioNTech	Yes

Call center

3 call center cases

1 unsuccessful · 2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): 6 days postpartum

2021-01-02

Systemic reaction (other): 1 week postpartum

Release 9 — 6 months, dose 2

2021-07-23

Symptoms: Asthma flair and colitis.

Release 10 — day 35, dose 3

2021-11-09

Symptoms: Pregnant

Release 10 — day 42, dose 3

2021-11-18

Symptoms: Acute MDRO pyelo

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthma	✓	·	✓
SD	Colitis	✓	·	✓
SD	Pre-existing disease	✓	·	✓
SD	Pregnancy	·	·	✓
SD	Pyelonephritis acute	·	·	✓
SRO	Postpartum disorder	✓	✓	✓
SRO	Postpartum state	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release